{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:31:30Z","timestamp":1790721090172,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.blre.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T03:31:46Z","timestamp":1398137506000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Michelle A.H.","family":"Sonneveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moniek P.M.","family":"de Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.96.4.1102","article-title":"Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"96","author":"Folsom","year":"1997","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.blre.2014.04.003_bb0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.ATV.12.9.1063","article-title":"The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group","volume":"12","author":"Cortellaro","year":"1992","journal-title":"Arterioscler Thromb"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0020","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","article-title":"Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study","volume":"17","author":"Smith","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2014.04.003_bb0025","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","article-title":"The role of von Willebrand factor in thrombus formation","volume":"120","author":"Ruggeri","year":"2007","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor-cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0035","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.blre.2014.04.003_bb0040","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.blre.2014.04.003_bb0045","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"4706","key":"10.1016\/j.blre.2014.04.003_bb0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.blre.2014.04.003_bb0065","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.blre.2014.04.003_bb0070","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1093\/nar\/13.13.4699","article-title":"Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene","volume":"13","author":"Verweij","year":"1985","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0080","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.2009.08052.x","article-title":"Platelet von Willebrand factor\u2013structure, function and biological importance","volume":"148","author":"McGrath","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0095","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","article-title":"von Willebrand factor, endothelial dysfunction, and cardiovascular disease","volume":"4","author":"Vischer","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.blre.2014.04.003_bb0100","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","article-title":"von Willebrand factor and coronary heart disease: prospective study and meta-analysis","volume":"23","author":"Whincup","year":"2002","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0105","doi-asserted-by":"crossref","first-page":"e55175","DOI":"10.1371\/journal.pone.0055175","article-title":"Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses","volume":"8","author":"Willeit","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2141.1999.01317.x","article-title":"Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study","volume":"105","author":"Rumley","year":"1999","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0120","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1538-7836.2009.03574.x","article-title":"Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men","volume":"7","author":"Wannamethee","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.blre.2014.04.003_bb0125","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1161\/ATVBAHA.109.192740","article-title":"Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort","volume":"29","author":"Kucharska-Newton","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.blre.2014.04.003_bb0130","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.106.635029","article-title":"Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study","volume":"115","author":"Tzoulaki","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2011.05.015","article-title":"Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women","volume":"129","author":"Wennberg","year":"2012","journal-title":"Thromb Res"},{"issue":"19","key":"10.1016\/j.blre.2014.04.003_bb0140","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jacc.2009.12.047","article-title":"Multimarker prediction of coronary heart disease risk: the Women's Health Initiative","volume":"55","author":"Kim","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.blre.2014.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/eurheartj\/ehn331","article-title":"Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study","volume":"29","author":"Empana","year":"2008","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.blre.2014.04.003_bb0150","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.blre.2014.04.003_bb0155","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.ATV.13.12.1829","article-title":"Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"13","author":"Folsom","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood-2006-07-038166","article-title":"ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men","volume":"109","author":"Chion","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0165","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1538-7836.2010.03896.x","article-title":"Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood-2011-09-380618","article-title":"High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women","volume":"119","author":"Andersson","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/hrt.66.5.351","article-title":"von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death","volume":"66","author":"Jansson","year":"1991","journal-title":"Br Heart J"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0180","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9343(92)90198-K","article-title":"Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris","volume":"93","author":"Vaziri","year":"1992","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001721-199909000-00008","article-title":"von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis","volume":"10","author":"Blann","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0190","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.ATV.20.8.2019","article-title":"Plasma levels of tissue plasminogen activator\/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study","volume":"20","author":"Wiman","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0609.2006.00656.x","article-title":"Procoagulant factors and the risk of myocardial infarction in young women","volume":"77","author":"Tanis","year":"2006","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2006.03.011","article-title":"Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction","volume":"115","author":"Tousoulis","year":"2007","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjcard.2007.03.095","article-title":"Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction","volume":"100","author":"Matsukawa","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1538-7836.2008.02902.x","article-title":"Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack","volume":"6","author":"Crawley","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00380-008-1053-x","article-title":"Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation","volume":"23","author":"Horii","year":"2008","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9149(00)01355-2","article-title":"Role of novel markers of inflammation in patients with stable coronary heart disease","volume":"87","author":"Hoffmeister","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0049-3848(01)00399-1","article-title":"Increased levels of endothelial haemostatic markers in patients with coronary heart disease","volume":"105","author":"Schumacher","year":"2002","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1160\/TH09-08-0568","article-title":"Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease","volume":"103","author":"Miura","year":"2010","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0240","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2009.04.013","article-title":"Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients","volume":"207","author":"Bongers","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.blre.2014.04.003_bb0260","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0265","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/14017430600925300","article-title":"Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study)","volume":"40","author":"Ruef","year":"2006","journal-title":"Scand Cardiovasc J"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1994.tb05079.x","article-title":"Factor VIII, ABO blood group and the incidence of ischaemic heart disease","volume":"88","author":"Meade","year":"1994","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.blre.2014.04.003_bb0275","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study","volume":"112","author":"Smith","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/HJR.0b013e3280e129d0","article-title":"Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study","volume":"14","author":"May","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"12","key":"10.1016\/j.blre.2014.04.003_bb0285","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1538-7836.2009.03603.x","article-title":"Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study","volume":"7","author":"Carcaillon","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0290","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1538-7836.2011.04314.x","article-title":"Relationship between thrombospondin gene variations, von Willebrand factor levels and the risk of coronary heart disease in an older population","volume":"9","author":"van Loon","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0300","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.blre.2014.04.003_bb0305","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1538-7836.2007.02677.x","article-title":"A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease","volume":"5","author":"Woodward","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"21","key":"10.1016\/j.blre.2014.04.003_bb0310","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","author":"Thogersen","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/hrt.55.1.58","article-title":"Haemostatic function in myocardial infarction","volume":"55","author":"Hamsten","year":"1986","journal-title":"Br Heart J"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.atherosclerosis.2012.06.067","article-title":"Prognostic markers in young patients with premature coronary heart disease","volume":"224","author":"van Loon","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0325","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1998.00626.x","article-title":"Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants","volume":"100","author":"Smith","year":"1998","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0330","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1111\/j.1538-7836.2006.02161.x","article-title":"Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction","volume":"4","author":"Kaikita","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2014.04.003_bb0335","first-page":"918312","article-title":"Von Willebrand factor and oxidative stress parameters in acute coronary syndromes","author":"Koprivica","year":"2011","journal-title":"Oxidative Med Cell Longev"},{"issue":"19","key":"10.1016\/j.blre.2014.04.003_bb0340","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.99.19.2517","article-title":"Thrombogenic factors and recurrent coronary events","volume":"99","author":"Moss","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2796.2000.00715.x","article-title":"Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regarding unstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics","volume":"248","author":"Nielsen","year":"2000","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1160\/TH02-10-0185","article-title":"Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease\u2013a 13-year follow-up","volume":"90","author":"Niessner","year":"2003","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0355","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2008.04.020","article-title":"Premature coronary artery disease in young (age<45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers","volume":"136","author":"Pineda","year":"2009","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2009.02.019","article-title":"The prognostic value of biomarkers after a premature myocardial infarction","volume":"143","author":"Pineda","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00001721-200101000-00003","article-title":"Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events","volume":"12","author":"Redondo","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MBC.0b013e32832a5fd1","article-title":"Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8years","volume":"20","author":"Thogersen","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0380","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0049-3848(89)90317-4","article-title":"von Willebrand factor is an acute phase reactant in man","volume":"53","author":"Pottinger","year":"1989","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","article-title":"von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?","volume":"34","author":"Lip","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0395","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.80.4.334","article-title":"von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10year follow up of survivors of acute myocardial infarction","volume":"80","author":"Jansson","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.blre.2014.04.003_bb0400","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.ijcard.2013.03.043","article-title":"Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study","volume":"168","author":"Omicron Hartaigh","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0405","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.thromres.2012.12.001","article-title":"Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients","volume":"131","author":"Hyseni","year":"2013","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0410","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2004-03-1106","article-title":"Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.04.003_bb0415","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijcard.2012.09.056","article-title":"Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation","volume":"168","author":"Freynhofer","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0420","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1538-7836.2010.03863.x","article-title":"von Willebrand factor propeptide and the occurrence of a first ischemic stroke","volume":"8","author":"van Schie","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3\u20134","key":"10.1016\/j.blre.2014.04.003_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09537109876618","article-title":"Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome","volume":"9","author":"Bath","year":"1998","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0049-3848(93)90145-E","article-title":"Changes of von Willebrand factor and antithrombin III levels in acute stroke: difference between thrombotic and haemorrhagic stroke","volume":"72","author":"Liu","year":"1993","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0435","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0038-1656120","article-title":"von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality","volume":"77","author":"Catto","year":"1997","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0440","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00001721-200206000-00010","article-title":"Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project","volume":"13","author":"Lip","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0445","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2009.07.047","article-title":"Active von Willebrand factor and the risk of stroke","volume":"208","author":"van Schie","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(01)00635-9","article-title":"Endothelial markers and adhesion molecules in acute ischemic stroke\u2013sequential change and differences in stroke subtype","volume":"161","author":"Kozuka","year":"2002","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0455","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2010.04134.x","article-title":"Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke","volume":"9","author":"Hanson","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0460","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","article-title":"High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability","volume":"37","author":"Bongers","year":"2006","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH08-06-0375","article-title":"Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke","volume":"101","author":"Licata","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0470","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.STR.14.4.511","article-title":"Platelet function tests in thrombotic cerebrovascular disorders","volume":"14","author":"Uchiyama","year":"1983","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.blre.2014.04.003_bb0475","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.STR.0000086466.32421.F4","article-title":"Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes","volume":"34","author":"Cherian","year":"2003","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0480","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/CS20080372","article-title":"Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)","volume":"116","author":"Pinto","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0485","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/49.10.1733","article-title":"Early biomarkers of stroke","volume":"49","author":"Reynolds","year":"2003","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0490","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00001721-200112000-00006","article-title":"Haemostasis in ischaemic stroke and vascular dementia","volume":"12","author":"Stott","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2014.04.003_bb0495","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/STROKEAHA.111.636373","article-title":"Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men","volume":"43","author":"Wannamethee","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0500","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000247603","article-title":"Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study","volume":"28","author":"Gottesman","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0505","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000054767","article-title":"Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study","volume":"20","author":"Knuiman","year":"2001","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0510","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke: the Rotterdam study","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0515","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0037-1612975","article-title":"Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke","volume":"87","author":"Johansson","year":"2002","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0520","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.49.6.1552","article-title":"Von Willebrand factor and risk of ischemic stroke","volume":"49","author":"Qizilbash","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0530","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000210433","article-title":"New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke","volume":"27","author":"Amarenco","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0535","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.STR.0000239694.19359.88","article-title":"Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0540","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.atherosclerosis.2013.07.046","article-title":"Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients","volume":"230","author":"Sonneveld","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0545","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1253\/circj.71.321","article-title":"Time course of platelet activation and von Willebrand factor in patients with non-valvular atrial fibrillation after ischemic stroke","volume":"71","author":"Yip","year":"2007","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0550","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1172\/JCI108985","article-title":"Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis","volume":"61","author":"Fuster","year":"1978","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0555","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.RES.51.5.587","article-title":"Arteriosclerosis in normal and von Willebrand pigs: long-term prospective study and aortic transplantation study","volume":"51","author":"Fuster","year":"1982","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0560","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V98.5.1424","article-title":"Localized reduction of atherosclerosis in von Willebrand factor-deficient mice","volume":"98","author":"Methia","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0565","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.blre.2012.05.002","article-title":"Von Willebrand factor deficiency and atherosclerosis","volume":"26","author":"van Galen","year":"2012","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0570","first-page":"403","article-title":"Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype","volume":"140","author":"Nichols","year":"1992","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0575","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1076029607303613","article-title":"Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction","volume":"13","author":"Bilora","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0580","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/hc3501.094232","article-title":"Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency","volume":"104","author":"Sramek","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0585","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0038-1649665","article-title":"Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi","volume":"70","author":"Federici","year":"1993","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0590","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/01.CIR.0000112567.53841.10","article-title":"Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients","volume":"109","author":"Sramek","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0595","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.12194","article-title":"Reduced prevalence of arterial thrombosis in von Willebrand disease","volume":"11","author":"Sanders","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0600","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0605","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"issue":"44","key":"10.1016\/j.blre.2014.04.003_bb0610","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0615","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?","volume":"130","author":"Soejima","year":"2001","journal-title":"J Biochem"},{"issue":"6855","key":"10.1016\/j.blre.2014.04.003_bb0620","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0625","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2008-04-148759","article-title":"Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity","volume":"112","author":"Gao","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0630","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0635","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1182\/blood-2006-02-002139","article-title":"Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts","volume":"108","author":"Shang","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0640","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hoc.2007.06.003","article-title":"Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency","volume":"21","author":"Tsai","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0645","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","article-title":"ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock","volume":"5","author":"Kremer Hovinga","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0650","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1160\/TH09-06-0376","article-title":"Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome","volume":"103","author":"Bongers","year":"2010","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0655","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3324\/haematol.10262","article-title":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis","volume":"92","author":"Nguyen","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0665","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1160\/TH04-08-0467","article-title":"Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation","volume":"93","author":"Reiter","year":"2005","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.blre.2014.04.003_bb0670","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0675","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen","year":"1999","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0680","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1538-7836.2004.00601.x","article-title":"ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate","volume":"2","author":"Whitelock","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0685","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH03-11-0675","article-title":"An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations","volume":"91","author":"Zhou","year":"2004","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0690","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0695","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0705","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1160\/TH10-06-0417","article-title":"Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies","volume":"105","author":"Palla","year":"2011","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.blre.2014.04.003_bb0710","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1538-7836.2008.03099.x","article-title":"Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2014.04.003_bb0715","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0950-3536(98)80064-4","article-title":"Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura","volume":"11","author":"Furlan","year":"1998","journal-title":"Baillieres Clin Haematol"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0720","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.seminhematol.2003.10.002","article-title":"Genetic defects leading to hereditary thrombotic thrombocytopenic purpura","volume":"41","author":"Kokame","year":"2004","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0725","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1523-1755.2004.00841.x","article-title":"Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome (TTP\/HUS)","volume":"66","author":"Licht","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0730","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.blre.2014.04.003_bb0735","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0740","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","article-title":"Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies","volume":"9","author":"Plaimauer","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0745","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(52)90022-3","article-title":"An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries; an undescribed disease","volume":"13","author":"Moschcowitz","year":"1952","journal-title":"Am J Med"},{"issue":"22","key":"10.1016\/j.blre.2014.04.003_bb0750","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0755","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.2003.04257.x","article-title":"Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation","volume":"121","author":"Yoo","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2014.04.003_bb0760","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0049-3848(01)00320-6","volume":"103","author":"He","year":"2001","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0765","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.23735","article-title":"Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study","volume":"73","author":"Lambers","year":"2013","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0770","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0775","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2008.09.012","article-title":"Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation","volume":"124","author":"Uemura","year":"2009","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.blre.2014.04.003_bb0780","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/ATVBAHA.111.232991","article-title":"Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation","volume":"31","author":"Ammash","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.blre.2014.04.003_bb0785","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2011-09-376202","article-title":"ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice","volume":"119","author":"Gandhi","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0790","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/ATVBAHA.112.247262","article-title":"Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model","volume":"32","author":"Jin","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/j.blre.2014.04.003_bb0795","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0800","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2009-06-230110","article-title":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion","volume":"115","author":"Fujioka","year":"2010","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.blre.2014.04.003_bb0805","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1182\/blood-2012-06-439935","article-title":"Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"De Meyer","year":"2012","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.blre.2014.04.003_bb0810","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2014.04.003_bb0815","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1538-7836.2012.04822.x","article-title":"ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice","volume":"10","author":"Khan","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.04.003_bb0820","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1160\/TH12-09-0674","article-title":"ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction","volume":"108","author":"Doi","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2014.04.003_bb0825","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jth.12456","article-title":"ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism","volume":"12","author":"Gandhi","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2014.04.003_bb0830","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2007.02818.x","article-title":"ABO(H) blood groups and vascular disease: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"6741","key":"10.1016\/j.blre.2014.04.003_bb0835","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/bmj.300.6741.1679","article-title":"ABO blood group and ischaemic heart disease in British men","volume":"300","author":"Whincup","year":"1990","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.blre.2014.04.003_bb0840","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2011.04243.x","article-title":"Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review","volume":"9","author":"van Schie","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2014.04.003_bb0845","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1538-7836.2012.04634.x","article-title":"Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study","volume":"10","author":"Van Schie","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.blre.2014.04.003_bb0850","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","article-title":"von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population","volume":"10","author":"van Loon","year":"2012","journal-title":"J Thromb Haemost"}],"updated-by":[{"DOI":"10.1016\/j.blre.2014.09.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:21:56Z","timestamp":1759436516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":161,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0268960X14000344"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.04.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}